Nitisinone - Swedish Orphan Biovitrum
At a glance
- Drug Originator Syngenta
- Drug Licenced by Astellas Pharma; BL-&-H; Rare Disease Therapeutics; Swedish Orphan Biovitrum
- Drug Class Antiparkinsonians; Cyclohexanones; Nitrobenzoates; Small molecules
- Mechanism of Action 4-hydroxyphenylpyruvate dioxygenase inhibitors; Dopamine release stimulants
- USA Patent Applicants SWEDISH ORPHAN
- USA Patents 3
- NDAs 2
- International Patents 24
- Patent Applications 709
Disclaimer